|
Volumn 75, Issue 5, 2002, Pages 493-498
|
Long-term follow-up of allogeneic bone marrow transplantation after reduced-intensity conditioning in patients with chronic myelogenous leukemia in the chronic phase.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYCLOPHOSPHAMIDE;
CYTARABINE;
GRANULOCYTE COLONY STIMULATING FACTOR;
ADULT;
ALLOTRANSPLANTATION;
ARTICLE;
BONE MARROW TRANSPLANTATION;
CHRONIC MYELOID LEUKEMIA;
CLINICAL TRIAL;
FEMALE;
FOLLOW UP;
GRAFT SURVIVAL;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
ISOGRAFT;
MALE;
METHODOLOGY;
MIDDLE AGED;
PILOT STUDY;
TREATMENT OUTCOME;
WHOLE BODY RADIATION;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BONE MARROW TRANSPLANTATION;
CYCLOPHOSPHAMIDE;
CYTARABINE;
FEMALE;
FOLLOW-UP STUDIES;
GRAFT SURVIVAL;
GRANULOCYTE COLONY-STIMULATING FACTOR;
HUMANS;
LEUKEMIA, MYELOID, CHRONIC;
MALE;
MIDDLE AGED;
PILOT PROJECTS;
TRANSPLANTATION CONDITIONING;
TRANSPLANTATION, HOMOLOGOUS;
TRANSPLANTATION, ISOGENEIC;
TREATMENT OUTCOME;
WHOLE-BODY IRRADIATION;
|
EID: 0346363081
PISSN: 09255710
EISSN: None
Source Type: Journal
DOI: 10.1007/BF02982112 Document Type: Article |
Times cited : (9)
|
References (0)
|